Glucose monitors were once only used by diabetics, but that is changing fast. Now, many health-conscious people are using these devices to track their blood sugar and improve their overall health. This growing interest is pushing the market for glucose monitors to new heights. From athletes to biohackers, non-diabetics are investing in continuous glucose monitoring (CGM) devices to optimize their diet, fitness, and long-term health. Let’s dive into the numbers behind this explosive market and what they mean for the future.
1. The global continuous glucose monitoring (CGM) market was valued at approximately $5.2 billion in 2022 and is expected to reach $16 billion by 2030
The demand for CGMs is skyrocketing, and this is reflected in the market’s massive growth. In 2022, the global CGM industry was worth $5.2 billion. By 2030, it is expected to hit $16 billion, more than tripling in value in just eight years.
This rapid expansion is happening for several reasons. First, people are more aware of the importance of blood sugar regulation, even if they don’t have diabetes.
Second, technology has made CGMs smaller, more comfortable, and easier to use. Third, the rise of health tracking through smart devices has created a perfect opportunity for CGMs to fit into existing ecosystems.
For investors and entrepreneurs, this means the CGM market has massive potential. Companies that innovate in areas like non-invasive glucose monitoring, AI-powered insights, and app integrations will be well-positioned for success.
Meanwhile, consumers should expect more options, better affordability, and improved features in the coming years.
2. The CGM market is growing at a CAGR of around 15% from 2023 to 2030
A 15% compound annual growth rate (CAGR) means the CGM market isn’t just growing—it’s accelerating. Compared to other healthcare segments, this is an impressive number. Many industries struggle to maintain even a 5-10% growth rate.
This growth is being fueled by two main factors: increased adoption by non-diabetics and continuous advancements in CGM technology. Unlike traditional finger-prick glucose tests, CGMs provide real-time data, allowing users to make instant changes to their diet and lifestyle.
For businesses in the health tech sector, this trend highlights the need to develop more user-friendly, affordable, and feature-rich glucose monitoring solutions. Companies should also consider partnerships with wellness brands and fitness apps to expand their reach.
3. Non-diabetic users account for approximately 15-20% of total CGM sales as of 2023
A growing number of CGM users don’t have diabetes. In 2023, around 15-20% of total CGM sales came from non-diabetic users. This number is expected to grow as more people realize the benefits of glucose tracking.
The appeal lies in the ability to understand how food, exercise, and stress affect blood sugar levels. Many people find that CGMs help them avoid energy crashes, improve workout performance, and make smarter food choices.
This shift shows that CGMs are becoming a mainstream wellness tool rather than just a medical necessity.
Companies in this space should focus on marketing CGMs as lifestyle devices rather than purely medical tools. Messaging that emphasizes performance, longevity, and optimized health will attract more non-diabetic consumers.
4. The adoption of glucose monitors among health-conscious individuals has increased by over 40% in the past five years
People are taking their health into their own hands, and CGMs are becoming a key part of their toolkit. Adoption among health-conscious consumers has jumped by over 40% in just five years.
This surge is partly due to influencers and wellness experts promoting glucose tracking as a way to improve metabolic health. With more awareness, consumers are realizing that blood sugar levels impact not just diabetes but also weight management, mental clarity, and energy levels.
Brands should focus on educating consumers about how CGMs can help them achieve their health goals. Clear and engaging content, user testimonials, and easy-to-understand data insights will be critical for continued market expansion.
5. The wellness and preventive healthcare industry, including CGMs, is expected to exceed $7 trillion globally by 2030
The wellness industry is one of the fastest-growing sectors in the world. By 2030, it is expected to surpass $7 trillion. CGMs are playing a big role in this growth because they provide real-time feedback, allowing users to take preventive action before health problems arise.
Preventive healthcare is becoming a priority as people look for ways to avoid chronic diseases and extend their lifespan. Instead of waiting for a doctor to diagnose a problem, consumers are using CGMs to make proactive changes.
For businesses, this means there’s a massive opportunity in wellness-focused CGMs. Companies that integrate glucose tracking with other health metrics like sleep, stress, and activity will have a competitive edge.
6. CGM penetration among athletes and fitness enthusiasts has risen by more than 50% since 2020
Athletes are always looking for ways to optimize performance, and CGMs are giving them a competitive edge. Since 2020, the adoption of CGMs among athletes and fitness enthusiasts has grown by over 50%.
This growth is driven by the ability to fine-tune nutrition and training based on real-time glucose data. Athletes use CGMs to determine which foods fuel them best, how different workouts impact their energy levels, and when to refuel for peak performance.
Companies should consider creating athlete-specific CGMs with advanced performance tracking features. Collaborations with sports brands, trainers, and professional athletes could also boost awareness and credibility.
7. Biohacking and longevity-focused consumers make up around 25% of non-diabetic CGM users
The biohacking movement is growing, and CGMs are becoming a key tool for people who want to extend their lifespan and optimize their health. Around 25% of non-diabetic CGM users are focused on biohacking and longevity.
These consumers are highly engaged and willing to invest in cutting-edge technology. They use CGMs to test different diets, track fasting effectiveness, and monitor blood sugar fluctuations to prevent long-term metabolic damage.
Companies should tailor marketing efforts toward this group by emphasizing personalized health optimization and longevity benefits. Partnerships with biohacking influencers and longevity researchers could also help drive adoption.
8. Wearable glucose monitoring devices have seen an increase in venture capital funding, exceeding $1 billion in 2023
Investment in glucose monitoring technology is accelerating. In 2023 alone, venture capital funding for CGM and wearable glucose tracking devices surpassed $1 billion. This surge in investment highlights the growing confidence in the market’s potential.
Startups and tech giants are racing to develop the next generation of CGMs, with a strong focus on non-invasive sensors that don’t require skin penetration. Investors see huge potential in expanding glucose monitoring beyond diabetes care and into the broader wellness industry.
For entrepreneurs and innovators, this trend presents a great opportunity. If you’re looking to enter the market, securing funding might be easier now than ever before. However, competition is fierce, and differentiation is key.
Innovations in accuracy, comfort, integration with existing health platforms, and affordability will stand out.
9. Abbott and Dexcom control over 80% of the global glucose monitoring market
Abbott and Dexcom dominate the CGM market, with a combined market share of over 80%. Both companies have developed highly reliable and widely adopted CGMs, such as the Freestyle Libre (Abbott) and Dexcom G7.
Despite their dominance, opportunities remain for new players. While Abbott and Dexcom focus primarily on diabetes management, companies specializing in wellness-oriented CGMs can carve out their own niche.
Startups offering better user experience, seamless smartwatch integration, or non-invasive glucose tracking can gain a foothold in the market.
For consumers, this market dominance means reliability but also limited competition, which can keep prices high. As more companies enter the space, expect better pricing and more innovative features.
10. The subscription-based CGM model for non-diabetics has grown by over 60% annually
Instead of one-time purchases, more consumers are subscribing to CGM services. The subscription-based model for non-diabetic CGM users has grown by over 60% annually, showing strong demand for continuous access to glucose monitoring.
Companies like Levels, Veri, and NutriSense are leading this space. Their services go beyond providing a CGM—they also offer personalized insights, nutritional coaching, and AI-driven analytics. This business model works well because it makes glucose tracking more actionable for consumers.
For businesses, the subscription model provides recurring revenue and stronger customer retention. However, to stand out, companies should focus on user-friendly software, better data interpretation, and ongoing health education.
11. The average cost of a non-diabetic CGM subscription ranges between $100 and $300 per month
Tracking glucose levels as a non-diabetic isn’t cheap. The average cost of a CGM subscription for wellness tracking falls between $100 and $300 per month, depending on the provider and service level.
This price point puts CGMs in the premium health tech category. While many health-conscious individuals are willing to pay for valuable insights, lowering costs could accelerate market adoption. More competition and technological advancements will likely bring prices down in the future.
For businesses, finding ways to make CGMs more accessible—whether through insurance, employer wellness programs, or bundled health tracking services—will be key to long-term growth.
12. Over 65% of CGM users report using the data for optimizing metabolic health rather than managing diabetes
A significant majority—over 65% of CGM users—use these devices not for diabetes management, but for metabolic health optimization. This means they are tracking their glucose to improve energy levels, lose weight, enhance fitness, and prevent long-term health issues.
This shift in usage is a major indicator of where the market is headed. People are realizing that glucose stability affects everything from brain function to weight gain.
Companies should focus on educational marketing that highlights these benefits. Simplifying data interpretation for users will also be crucial in keeping them engaged with CGM technology.
13. The global wellness tech industry, which includes glucose monitoring, is growing at a CAGR of 9%
The wellness tech industry—which includes wearables, personalized health apps, and CGMs—is expanding rapidly, with a projected CAGR of 9%. This growth highlights how technology is shaping the future of health management.
As people become more proactive about their health, demand for personalized tracking devices is increasing. CGMs fit perfectly into this trend, offering real-time metabolic insights that traditional health tracking devices do not provide.
Businesses should integrate glucose monitoring into larger wellness ecosystems. Smart partnerships with fitness apps, meal tracking platforms, and telehealth providers will enhance user experience and drive adoption.
14. CGM device sales have surged by over 30% annually due to increasing health awareness
Health awareness campaigns, social media, and the influence of longevity-focused experts have contributed to a 30% annual increase in CGM device sales.
People are now questioning how their daily habits impact their long-term health. The ability to see the effects of food, exercise, and stress in real time makes CGMs incredibly valuable.
For companies, leveraging influencers and thought leaders in the health space can be a powerful marketing strategy. The more consumers understand how glucose affects their daily lives, the more demand for CGMs will grow.
15. In the U.S., around 10% of CGM prescriptions are now written for non-diabetic patients
In a major shift, 10% of CGM prescriptions in the U.S. are now being written for non-diabetic patients. Doctors are recognizing the value of continuous glucose monitoring for metabolic health, weight management, and chronic disease prevention.
This trend suggests that CGMs may soon be covered by insurance for non-diabetic use cases, making them more accessible to the general public.
Businesses in this space should work toward establishing relationships with healthcare providers. If CGMs become a routine part of preventive care, the market will expand even further.
16. Over 80% of non-diabetic CGM users report improved dietary habits after using the device
One of the most powerful impacts of using a CGM is behavior change. Over 80% of non-diabetic users report improving their diet after seeing how their blood sugar reacts to different foods.
Many people assume that eating “healthy” is enough, but CGMs show that reactions to food are highly individual. A meal that keeps one person’s glucose stable may cause spikes in another.
For companies, the key is education. Brands should focus on making it easy for users to interpret their data and take meaningful action. Partnering with nutritionists, creating easy-to-follow guides, and offering personalized meal suggestions will enhance the user experience.
17. The wearable biosensor market, including glucose monitors, is projected to surpass $40 billion by 2027
The broader wearable biosensor market, which includes CGMs, is projected to exceed $40 billion by 2027. This growth is driven by the rising popularity of real-time health tracking.
Companies like Apple and Google are investing heavily in wearable biosensors. While CGMs currently require small needles, non-invasive glucose monitors could be the next breakthrough.
For businesses, the future lies in seamless integration. CGMs that work effortlessly with existing wearables, apps, and digital health platforms will gain mass adoption.
18. Apple and Google have both invested in non-invasive glucose monitoring technology for wearables
Tech giants Apple and Google are working on non-invasive glucose tracking for wearables. If successful, this would eliminate the need for patches or sensors inserted under the skin.
This development could be a game changer, making glucose tracking as common as heart rate monitoring.
For existing CGM companies, this is both a challenge and an opportunity. Companies that stay ahead of the curve by improving usability, AI-powered insights, and affordability will thrive even if non-invasive options become available.
19. The Asia-Pacific region is expected to see the fastest CGM adoption growth at a CAGR of 18%
The Asia-Pacific (APAC) region is emerging as a major player in the CGM market, with adoption projected to grow at an impressive 18% CAGR. This is significantly higher than in North America and Europe, where adoption is already more established.
Several factors are driving this growth. First, rising health awareness in countries like China, India, Japan, and South Korea is pushing consumers to invest in wellness technologies.
Second, lifestyle-related diseases such as obesity and metabolic syndrome are on the rise, leading people to track their blood sugar more proactively. Third, government initiatives promoting digital health solutions are creating a more supportive regulatory environment.
For businesses, this signals a huge market opportunity. Companies expanding into APAC should consider localized marketing, partnerships with fitness and nutrition brands, and culturally tailored health insights.
Pricing strategies will also be key, as affordability can be a major factor in these markets.
20. More than 50% of non-diabetic CGM users are in the U.S. and Europe
Currently, over 50% of non-diabetic CGM users are based in the United States and Europe, where consumer interest in biohacking, longevity, and preventive health is strongest.
The U.S. market is fueled by a tech-savvy population, a well-developed wearable tech ecosystem, and increasing availability of CGM subscription services like Levels and NutriSense. In Europe, consumers are drawn to CGMs for their role in metabolic health optimization and sports performance tracking.
However, as the APAC and Middle Eastern markets grow, this percentage may shift. Companies currently focusing on Western markets should start laying the groundwork for global expansion, particularly in fast-growing regions where CGM adoption is increasing rapidly.
21. CGM integration with smartwatches and fitness trackers is expected to grow by over 100% in the next five years
The future of CGMs is seamless integration with wearable technology. In the next five years, CGM-smartwatch integrations are expected to grow by more than 100%.
Companies like Apple, Samsung, and Garmin are actively exploring ways to bring real-time glucose tracking to their smartwatches. Apple’s rumored non-invasive glucose sensor for the Apple Watch could be a game-changer if it becomes accurate enough for consumer use.
For CGM brands, this trend presents both opportunities and challenges. If tech giants integrate glucose tracking into mainstream smartwatches, traditional CGM companies may need to pivot towards better software, personalized insights, and deeper integrations with existing health tracking platforms to stay competitive.
22. Studies suggest that non-diabetic CGM users reduce their sugar intake by 30-40% on average
One of the most immediate effects of using a CGM is dietary change. Studies show that non-diabetic CGM users reduce their sugar intake by 30-40% on average after seeing how high-sugar foods impact their blood sugar levels.
This is because CGMs provide real-time feedback on how food choices affect the body. Many users are surprised to learn that even “healthy” foods like fruit smoothies or granola bars can cause major glucose spikes.
As a result, they make better choices, swapping processed carbs for fiber-rich meals and protein-based snacks.
For businesses, this means a growing demand for CGM-friendly food products, meal planning services, and educational content.
Companies in the nutrition space should consider offering CGM-optimized meal plans or partnering with CGM brands to provide science-backed dietary recommendations.
23. Over 60% of high-performance athletes use CGMs to optimize training and recovery
Elite athletes are always looking for ways to improve performance, and CGMs have become a key tool in sports nutrition and recovery strategies. More than 60% of high-performance athletes now use CGMs to monitor glucose fluctuations and fine-tune their training.
CGMs help athletes determine:
- When to eat for sustained energy
- How different types of exercise impact glucose levels
- Which foods provide the best fuel for performance
- When to refuel to prevent fatigue
For brands, this presents an opportunity to market CGMs as performance-enhancing tools rather than just health-tracking devices. Collaborating with athletes, trainers, and sports nutritionists can help increase adoption in the fitness community.
24. CGM manufacturers are investing over $500 million annually in R&D for non-invasive sensors
The biggest limitation of CGMs today is the need for a sensor to be inserted under the skin. But this could soon change. CGM manufacturers are investing over $500 million annually in research and development (R&D) for non-invasive glucose monitoring technologies.
Non-invasive CGMs would eliminate needles, discomfort, and adhesive-related skin issues, making them more appealing to the general population. Some promising technologies include:
- Optical sensors that measure glucose through the skin
- Microwave technology that detects glucose molecules
- Sweat and tear-based glucose monitoring
Companies working in this space should focus on accuracy, reliability, and regulatory approvals, as these will be critical for mainstream adoption.
25. Regulatory approvals for CGMs are expanding, with non-diabetic applications gaining traction
Until recently, CGMs were mainly approved for diabetic use, but that’s changing. Regulatory agencies are expanding approvals to include non-diabetic applications, especially for metabolic health and weight management.
The U.S. FDA, Europe’s CE Mark, and other regulatory bodies are gradually recognizing the preventive benefits of glucose monitoring. This shift could open the door for insurance coverage, making CGMs more accessible to the general public.
Companies in this space should work closely with regulators to fast-track approvals for broader health applications. Additionally, lobbying for insurance reimbursement could help make CGMs more affordable for non-diabetic users.
26. Around 70% of non-diabetic CGM users are between the ages of 25 and 45
The majority of non-diabetic CGM users—about 70%—are between the ages of 25 and 45. This age group is highly engaged in fitness, longevity, and biohacking trends, making them the perfect target market.
Marketing strategies should focus on personalized health, performance optimization, and longevity benefits. Social media platforms like Instagram, TikTok, and YouTube are highly effective for reaching this demographic with influencer partnerships, educational videos, and interactive content.
27. CGM-related app downloads have increased by over 200% in the past three years
CGMs are only as good as the software that interprets their data, and this is driving a boom in CGM-related apps. Downloads have increased by over 200% in the past three years, showing strong demand for better data insights.
Successful CGM apps provide:
- Easy-to-understand glucose insights
- Personalized recommendations
- Integration with other health apps
For businesses, investing in smart, user-friendly app experiences is just as important as developing the hardware itself.
28. Personalized nutrition companies are partnering with CGM providers to enhance metabolic tracking
The Future of Nutrition is Data-Driven
Personalized nutrition is no longer just about counting calories or following general diet trends. With continuous glucose monitors (CGMs), people can now see how their bodies react to specific foods in real time.
This is revolutionizing the way individuals approach their diets, shifting the focus from generalized advice to truly personalized metabolic health strategies.
Nutrition companies are recognizing this shift and partnering with CGM providers to offer data-driven dietary solutions. These collaborations are not only enhancing consumer experiences but also creating new business opportunities for both industries.
29. The demand for real-time glucose tracking is expected to lead to a fivefold increase in non-diabetic CGM users by 2030
A Shift Toward Proactive Health Management
Glucose monitoring is no longer just for diabetics. The rise of real-time glucose tracking is turning continuous glucose monitors (CGMs) into mainstream wellness tools, helping non-diabetics improve their health, fitness, and longevity.
This demand is expected to cause a fivefold increase in non-diabetic CGM users by 2030, creating massive opportunities for businesses in the health, tech, and nutrition industries.
As consumers become more aware of how blood sugar impacts energy levels, weight management, mental clarity, and long-term health, CGMs are becoming a must-have tool rather than a niche medical device. This shift is not just a trend—it’s the future of personalized health.
30. Non-invasive glucose monitoring solutions are expected to disrupt the market by 2026
A Game-Changer in Glucose Tracking
The biggest limitation of current continuous glucose monitors (CGMs) is that they require a sensor to be inserted under the skin. While the technology has improved significantly, many consumers—especially non-diabetics—are hesitant to use devices that involve needles or adhesives.
This is why non-invasive glucose monitoring (NIGM) is set to disrupt the market. By 2026, we can expect the first commercially viable non-invasive CGMs, revolutionizing how people track their blood sugar.
These devices promise needle-free, pain-free, and hassle-free glucose monitoring, making them far more appealing to the general public.
For businesses, this shift represents both a challenge and a massive opportunity. Companies that embrace non-invasive technology early will gain a significant edge in the growing market for metabolic health tracking.
wrapping it up
The glucose monitoring market is on the brink of a massive transformation. What was once a tool exclusively for diabetics is now evolving into a mainstream health technology, set to impact fitness, longevity, nutrition, and overall well-being.
